Digging Up the Facts on CBS Corporation (CBS)

CBS Corporation (CBS) is an interesting player in the Services space, with a focus on Entertainment – Diversified. The stock has been active on the tape, currently trading at $51.90, down from yesterday’s close by -0.75%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.

Fundamental Analysis

CBS Corporation (CBS) currently trades with a market capitalization of $20.96 Billion. That value represents a market adjusting for revenues that have been growing by 48.86 % on a quarterly year/year basis as of the company’s last quarterly report.

You can get a sense of how sustainable that is by a levered free cash flow of $702 Million over the past twelve months. Generally speaking, earnings are expected to fall in coming quarters. Analysts are forecasting earnings of $1.18 on a per share basis this quarter. Perhaps, that suggests something about why 1.19% of the outstanding share supply is held by institutional investors.



Technical Analysis

Sometimes, we can understand most about a stock by simply looking at how it has been trading. Looking at the stock’s movement on the chart, CBS Corporation recorded a 52-week high of $70.10. It is now trading 18.2% off that level. The stock is trading $55.94 its 50-day moving average by 4.04%. The stock carved out a 52-week low down at $50.54.

In recent action, CBS Corporation (CBS) has made a move of -2.37% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 16.68, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 3.81% with $357.57 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of CBS.

SHARE
Previous articleTaking a Look at the Data Behind Ciena Corporation (CIEN)
Next articleAmicus Therapeutics, Inc. (FOLD): What’s the Story?